Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio

$2.72Billion– No. of Holdings #97

SUVRETTA CAPITAL MANAGEMENT, LLC Performance:

2024 Q2: -2.44%YTD: 8.53%2023: 16.5%

Performance for 2024 Q2 is -2.44%, and YTD is 8.53%, and 2023 is 16.5%.

About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in NEW YORK, NY. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.2 Billions. In it's latest 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $2.7 Billions as of 30 Jun, 2024.

The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are , INSM, KURA. The fund has invested 6.6% of it's portfolio in BIOHAVEN LTD and 6.2% of portfolio in INSMED INC.

The fund managers got completely rid off ARGENX SE, BICYCLE THERAPEUTICS PLC (BCYC) and FATE THERAPEUTICS INC (FATE) stocks. They significantly reduced their stock positions in MEREO BIOPHARMA GROUP PLC (MREO), MCKESSON CORP (MCK) and THE CIGNA GROUP (CI). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in SYSCO CORP (SYY), CONTINEUM THERAPEUTICS INC and ERASCA INC (ERAS). The fund showed a lot of confidence in some stocks as they added substantially to UNITEDHEALTH GROUP INC (UNH), BENITEC BIOPHARMA INC (BNTC) and PROKIDNEY CORP (PROK).

SUVRETTA CAPITAL MANAGEMENT, LLC Equity Portfolio Value

Last Reported on: 14 Aug, 2024

SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of -2.44% in the last quarter. In trailing 12 months, it's portfolio return was 20.29%.

New Buys

Ticker	$ Bought
sysco corp	37,187,100
contineum therapeutics inc	36,159,200
erasca inc	32,492,600
mcdonalds corp	28,143,000
tesla inc	26,696,600
abeona therapeutics inc	15,626,500
monte rosa therapeutics inc	9,944,660
exact sciences corp	3,975,720

New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC

Additions

Ticker	% Inc.
unitedhealth group inc	967
benitec biopharma inc	728
prokidney corp	141
apple inc	105
elevance health inc	79.56
zura bio ltd	70.56
intra-cellular therapies inc	63.26
eyepoint pharmaceuticals inc	37.51

Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC

Reductions

Ticker	% Reduced
mereo biopharma group plc	-97.95
mckesson corp	-96.77
the cigna group	-96.5
revance therapeutics inc	-96.35
natera inc	-58.94
elanco animal health inc	-50.00
verizon communications inc	-48.29
morgan stanley	-39.65

SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
akili inc	-1,112,560
fate therapeutics inc	-18,811,300
terns pharmaceuticals inc	-8,945,710
bicycle therapeutics plc	-22,770,500
cogent biosciences inc	-2,123,520
starbucks corp	-15,806,000
argenx se	-47,994,500
global pmts inc	-14,180,500

SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 52.9% of it's holdings in Healthcare sector.

Sector	%
Healthcare	52.9
Others	17
Technology	8.7
Communication Services	6.9
Consumer Cyclical	6.1
Consumer Defensive	3
Industrials	2.5
Financial Services	1.5
Basic Materials	1.4

Market Cap. Distribution

SUVRETTA CAPITAL MANAGEMENT, LLC has about 46.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	25
MEGA-CAP	21.6
SMALL-CAP	19.9
UNALLOCATED	18.3
MID-CAP	11.5
MICRO-CAP	3.6

Stocks belong to which Index?

About 71.4% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
RUSSELL 2000	36.5
S&P 500	34.9
Others	28.6

Top 5 Winners (%)		%
INSM	insmed inc	147.9 %
ALNY	alnylam pharmaceuticals inc	62.5 %
PINS	pinterest inc	26.3 %
PTGX	protagonist therapeutics inc	19.8 %
AAPL	apple inc	17.5 %

Top 5 Winners ($)		$
INSM	insmed inc	100.8 M
AAPL	apple inc	11.4 M
AMZN	amazon com inc	4.6 M
ORCL	oracle corp	4.0 M
PINS	pinterest inc	3.8 M

Top 5 Losers (%)		%
MRNS	marinus pharmaceuticals inc	-86.4 %
EYPT	eyepoint pharmaceuticals inc	-52.5 %
STRO	sutro biopharma inc	-43.4 %
RVNC	revance therapeutics inc	-36.0 %
KZR	kezar life sciences inc	-33.5 %

Top 5 Losers ($)		$
EYPT	eyepoint pharmaceuticals inc	-49.7 M
MRNS	marinus pharmaceuticals inc	-39.9 M
ETNB	89bio inc	-23.8 M
ACLX	arcellx inc	-22.6 M
STRO	sutro biopharma inc	-17.3 M

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC

SUVRETTA CAPITAL MANAGEMENT, LLC has 97 stocks in it's portfolio. About 40.7% of the portfolio is in top 10 stocks. EYPT proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.

Last Reported on: 14 Aug, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
A	agilent technologies inc	0.02	4,990	646,854	unchanged	0.00

AAPL	apple inc	2.81	363,357	76,530,200	added	105

ABC	cencora inc	0.10	12,488	2,813,550	unchanged	0.00

ABEO	abeona therapeutics inc	0.57	3,685,500	15,626,500	new

ABT	abbott labs	0.13	33,520	3,483,060	unchanged	0.00

ACLX	arcellx inc	3.07	1,516,250	83,682,100	reduced	-2.95

AGLE	spyre therapeutics inc	0.09	107,310	2,522,860	reduced	-33.92

AKLI	akili inc	0.00	0.00	0.00	sold off	-100

ALGN	align technology inc	0.01	1,100	265,573	unchanged	0.00

ALNY	alnylam pharmaceuticals inc	0.34	37,624	9,142,630	added	15.2

AMD	advanced micro devices inc	2.06	345,998	56,124,300	added	1.26

AMZN	amazon com inc	2.53	356,268	68,848,800	reduced	-0.19

ARQT	arcutis biotherapeutics inc	3.42	10,004,500	93,041,800	added	27.00

AVTR	avantor inc	0.06	71,850	1,523,220	unchanged	0.00

BAX	baxter intl inc	0.01	7,970	266,597	unchanged	0.00

BCYC	bicycle therapeutics plc	0.00	0.00	0.00	sold off	-100

BNTC	benitec biopharma inc	0.43	1,691,290	11,822,100	added	728

BSX	boston scientific corp	0.71	251,689	19,382,600	reduced	-16.94

CI	the cigna group	0.06	4,800	1,586,740	reduced	-96.5

CMG	chipotle mexican grill inc	0.92	398,500	24,966,000	unchanged	0.00